E-ISSN 2148-5607
RELATED ARTICLES
Editorial
Molecular detection of Mycobacterium tuberculosis in formalin-fixed, paraffin-embedded tissues and biopsies of gastrointestinal specimens using real-time polymerase chain reaction system
(Turk J Gastroenterol 2010; 21: 129-134)
DOI: 10.4318/tjg.2010.0070
β-catenin-independent noncanonical Wnt pathway might be induced in gastric cancers
(Turk J Gastroenterol 2010; 21: 224-230)
DOI: 10.4318/tjg.2010.0092
Is there any relationship between Behçet's disease and hepatit C virus?
(Turk J Gastroenterol 1998; 9: 10-13)
Frequency of HBsAg/anti-HCV seropositivity and its relationship with risk factors in extrahepatic malignancies
(Turk J Gastroenterol 1998; 9: 28-31)
Effect of anti-HCV positifity on response to hepatitis B virus vaccine in haemodialysis patients
(Turk J Gastroenterol 1998; 9: 105-107)
The quality of life in hemodialysis patients with chronic hepatitis C virus infection
(Turk J Gastroenterol 2009; 20: 243-246)
DOI: 10.4318/tjg.2009.0020
Prevelance and genotyping of hepatitis C virus RNA in Turkish patinets with non-A, non-B liver disease
(Turk J Gastroenterol 1998; 9: 208-212)
An epidemiological study of Entamoeba histolytica and Entmoeba dispar infection using polymerase chain reaction
(Turk J Gastroenterol 1998; 9: 374-376)
Hepatitis B and C virus in West-Central Turkey: Seroprevalence in healthy individuals admitted to a university hospital for routine health checks
(Turk J Gastroenterol 2006; 17: 267-272)
Determination of hepatitis B genotypes in patients with chronic hepatitis B virus infection in Turkey
(Turk J Gastroenterol 2005; 16: 183-187)
Predictive value of tissue cagA status in Helicobacter pylori infection
(Turk J Gastroenterol 2001; 12: 27-31)
Chronic hepatitis C with mixed cryoglubulinemia: A cade report
(Turk J Gastroenterol 1996; 7: 254-256)
Clinicopathologic features and risk factors for hepatocellular carcinoma: Results from a single center in southern Turkey
(Turk J Gastroenterol 2003; 14: 85-90)
Type 1 gastric carcinoid tumor: another extrahepatic manifestation of hepatitis C virus infection?
(Turk J Gastroenterol 2003; 14: 194-196)
Autoantibodies in chronic viral hepatitis and autoimmune hepatitis
(Turk J Gastroenterol 1997; 8: 381-384)
HCV genotypes in HCV related chronic hepatitis in Southeast Anatolia
(Turk J Gastroenterol 1999; 10: 249-252)
Prevalance of hepatitis B and hepatitis C infection in Leprosy patients
(Turk J Gastroenterol 1999; 10: 253-255)
Original Article
Risk factors for higher anti-HCV positivity in a border city in southern Turkey with unique population characteristics
(Turk J Gastroenterol 2012; 23: 574-579)
DOI: 10.4318/tjg.2012.0554
The impact of hepatitis C virus infection on long-term outcome in renal transplant patients
(Turk J Gastroenterol 2011; 22: 165-170)
DOI: 10.4318/tjg.2011.0236
Comparison of FISH, RFLP and agar dilution methods for testing clarithromycin resistance of Helicobacter pylori
(Turk J Gastroenterol 2014; 25: 75-80)
DOI: 10.5152/tjg.2014.4688
Hepatitis C virus genotype distribution in Turkey remains unchanged after a decade: Performance of phylogenetic analysis of the NS5B, E1, and 5’UTR regions in genotyping efficiency
(Turk J Gastroenterol 2014; 25: 405-410)
DOI: 10.5152/tjg.2014.7083
Can the Abbott RealTime hepatitis C virus assay be used to predict therapeutic outcomes in hepatitis C virus-infected patients undergoing triple therapy?
(Turk J Gastroenterol 2016; 27: 165-172)
DOI: 10.5152/tjg.2016.150300
Evaluation of fluvastatin in combination with the standard of care therapy (PEG-IFN/Ribavirin) in Egyptian patients with hepatitis C virus
(Turk J Gastroenterol 2015; 26: 511-516)
DOI: 10.5152/tjg.2015.15806
Liver - Original Article
Insulin/high-density lipoprotein cholesterol ratio: A newly-discovered predictor of esophageal varices in patients with hepatitis C virus-related cirrhosis in the absence of diabetes mellitus
(Turk J Gastroenterol 2019; 30: 155-162)
DOI: 10.5152/tjg.2018.18237
Poster
Real-world efficacy, safety and clinical outcomes of ombitasvir/ paritaprevir/ ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: Turkey experience
(Turk J Gastroenterol 2019; 30: 10-15)
DOI: 10.5152/tjg.2019.07
From cirrhosis to hepatocellular carcinoma: An investigation into hepatitis C viral oncogenesis using meta-analysis
(Turk J Gastroenterol 2019; 30: 26-28)
DOI: 10.5152/tjg.2019.15
The under water part of the iceberg: Anti-HCV positivity
(Turk J Gastroenterol 2019; 30: 48-49)
DOI: 10.5152/tjg.2019.31
Evaluation of anti-HCV-positive HCV RNA-negative patients: Is it a safe condition?
(Turk J Gastroenterol 2019; 30: 58-58)
DOI: 10.5152/tjg.2019.37
Key Words
Authors
All
Reviewer's Corner
Author’s Corner
Survey
AVES | Copyright © 2019 Turkish Society of Gastroenterology | Latest Update: 04.07.2019